Vaccine safety

The MHRA continually monitors both the safety and quality of the medicines, including vaccines, available on the UK market. The information and links in this section are intended as a source of information for parents, health professionals and others interested in vaccine safety. The MHRA position and conclusions of the Committee on Safety of Medicines (CSM) on a number of key vaccine topics are included as well as several sources of general information on vaccines and vaccine safety.

Human papillomavirus (HPV) vaccine
This sections includes details on vaccine safety, reporting of suspected side effects and further information.

› Human papillomavirus (HPV) vaccine

Measles, mumps and rubella (MMR) vaccine
This section includes links to: MHRA and CSM statements and documents about the alleged links between the MMR vaccine and autism and bowel disease; statements about unlicensed single vaccines; CSM advice on MMR and idiopathic thrombocytopenic purpura; and external links to further sources of information on the MMR vaccine.

› Measles, mumps and rubella (MMR) vaccine

Thiomersal (ethylmercury)-containing vaccines
This section includes links to: MHRA and CSM statements on the safety of thiomersal (ethylmercury)-containing vaccines and external links to further sources of information.

› Thiomersal (ethylmercury)-containing vaccines

Other vaccine topics and general sources of information
This section includes links to general information sources on vaccines.

› Other vaccine topics and general sources of information

Contact for further information  
For further information vaccine safety, please contact our Information Centre, 10-2, MHRA, Market Towers, 1 Nine Elms Lane, London SW8 5NQ, telephone 020 7084 2000, fax 020 7084 2353 or e-mail info@mhra.gsi.gov.uk.


Page last modified: 30 September 2008